Literature DB >> 25575133

Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice.

Masato Hosokawa1, Tetsuaki Arai, Masami Masuda-Suzukake, Hiromi Kondo, Takashi Matsuwaki, Masugi Nishihara, Masato Hasegawa, Haruhiko Akiyama.   

Abstract

Granulin (GRN) mutations have been identified in familial frontotemporal lobar degeneration patients with ubiquitin pathology. GRN transcript haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in frontotemporal lobar degeneration pathogenesis. Moreover, recent findings indicate that GRN mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer disease and corticobasal degeneration. To investigate the potential influence of a decline in PGRN protein on tau accumulation, P301L tau transgenic mice were interbred with GRN-deficient mice, producing P301L tau transgenic mice harboring the GRN hemizygote. Brains were collected from 13- and 19-month-old mice, and sequential extraction of proteins, immunoblotting, and immunohistochemical analyses were performed. Immunoblotting analysis revealed that tau phosphorylation was accelerated in the Tris-saline soluble fraction of 13-month-old and in the sarkosyl-insoluble fraction of 19-month-old P301L tau/GRN hemizygotes compared with those in fractions from P301L tau transgenic mice. Activity of cyclin-dependent kinases was also upregulated in the brains of P301L tau/GRN hemizygote mice. Although the mechanisms involved in these findings remain unknown, our data suggest that a reduction in PGRN protein might contribute to phosphorylation and intraneuronal accumulation of tau.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575133     DOI: 10.1097/NEN.0000000000000158

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

2.  Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.

Authors:  Lisa P Elia; Amanda R Mason; Amela Alijagic; Steven Finkbeiner
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

3.  Progranulin mutations in clinical and neuropathological Alzheimer's disease.

Authors:  Badri N Vardarajan; Dolly Reyes-Dumeyer; Angel L Piriz; Rafael A Lantigua; Martin Medrano; Diones Rivera; Ivonne Z Jiménez-Velázquez; Eden Martin; Margaret A Pericak-Vance; William Bush; Lindsay Farrer; Jonathan L Haines; Li-San Wang; Yuk Yee Leung; Gerard Schellenberg; Walter Kukull; Philip De Jager; David A Bennett; Julie A Schneider; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

Review 4.  The Role of PGRN in Alzheimer's Disease.

Authors:  Hua Jing; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

Review 5.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

Review 6.  Approaches to develop therapeutics to treat frontotemporal dementia.

Authors:  Lisa P Elia; Terry Reisine; Amela Alijagic; Steven Finkbeiner
Journal:  Neuropharmacology       Date:  2020-01-08       Impact factor: 5.250

7.  PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.

Authors:  Hui-Min Xu; Lin Tan; Yu Wan; Meng-Shan Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

8.  Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation.

Authors:  Masato Hosokawa; Hiromi Kondo; Geidy E Serrano; Thomas G Beach; Andrew C Robinson; David M Mann; Haruhiko Akiyama; Masato Hasegawa; Tetsuaki Arai
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

9.  Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Geidy E Serrano; Thomas G Beach; Douglas G Walker
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-10       Impact factor: 3.148

10.  Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.

Authors:  Anna Ochalek; Balázs Mihalik; Hasan X Avci; Abinaya Chandrasekaran; Annamária Téglási; István Bock; Maria Lo Giudice; Zsuzsanna Táncos; Kinga Molnár; Lajos László; Jørgen E Nielsen; Bjørn Holst; Kristine Freude; Poul Hyttel; Julianna Kobolák; András Dinnyés
Journal:  Alzheimers Res Ther       Date:  2017-12-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.